| Product NDC: | 68016-221 |
| Proprietary Name: | Severe Congestion and Cough MAX |
| Non Proprietary Name: | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE |
| Active Ingredient(s): | 20; 400; 10 mg/20mL; mg/20mL; mg/20mL & nbsp; DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68016-221 |
| Labeler Name: | Chain Drug Consortium, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20130101 |
| Package NDC: | 68016-221-00 |
| Package Description: | 177 mL in 1 BOTTLE (68016-221-00) |
| NDC Code | 68016-221-00 |
| Proprietary Name | Severe Congestion and Cough MAX |
| Package Description | 177 mL in 1 BOTTLE (68016-221-00) |
| Product NDC | 68016-221 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20130101 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Chain Drug Consortium, LLC |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 20; 400; 10 |
| Strength Unit | mg/20mL; mg/20mL; mg/20mL |
| Pharmaceutical Classes |